Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study.

dc.contributor.authorKuttel, Michelle Mary
dc.contributor.authorRavenscroft, Neil
dc.date.accessioned2019-06-04T07:38:11Z
dc.date.available2019-06-04T07:38:11Z
dc.date.issued2019-02-13
dc.description.abstractAlthough the branched capsular polysaccharides of Streptococcus agalactiae serotype III (GBSIII PS) and Streptococcus pneumoniae serotype 14 (Pn14 PS) differ only in the addition of a terminal sialic acid on the GBSIII PS side chains, these very similar polysaccharides are immunogenically distinct. Our simulations of GBSIII PS, Pn14 PS and the unbranched backbone polysaccharide provide a conformational rationale for the different antigenic epitopes identified for these PS. We find that side chains stabilize the proximal β dGlc(1→6) β dGlcNAc backbone linkage, restricting rotation and creating a well-defined conformational epitope at the branch point. This agrees with the glycotope structure recognized by an anti-GBSIII PS functional monoclonal antibody. We find the same dominant solution conformation for GBSIII and Pn14 PS: aside from the branch point, the backbone is very flexible with a “zig-zag” conformational habit, rather than the helix previously proposed for GBSIII PS. This suggests a common strategy for bacterial evasion of the host immune system: a flexible backbone that is less perceptible to the immune system, combined with conformationally-defined branch points presenting human-mimic epitopes. This work demonstrates how small structural features such as side chains can alter the conformation of a polysaccharide by restricting rotation around backbone linkages.en_US
dc.identifier.apacitationKuttel, M. M., & Ravenscroft, N. (2019). Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study. <i>Pharmaceuticals</i>, 12(1), 28. http://hdl.handle.net/11427/30191en_ZA
dc.identifier.chicagocitationKuttel, Michelle Mary, and Neil Ravenscroft "Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study." <i>Pharmaceuticals</i> 12, 1. (2019): 28. http://hdl.handle.net/11427/30191en_ZA
dc.identifier.citationKuttel, M. M., & Ravenscroft, N. (2019). Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study. Pharmaceuticals, 12(1), 28.
dc.identifier.ris TY - Journal Article AU - Kuttel, Michelle Mary AU - Ravenscroft, Neil AB - Although the branched capsular polysaccharides of Streptococcus agalactiae serotype III (GBSIII PS) and Streptococcus pneumoniae serotype 14 (Pn14 PS) differ only in the addition of a terminal sialic acid on the GBSIII PS side chains, these very similar polysaccharides are immunogenically distinct. Our simulations of GBSIII PS, Pn14 PS and the unbranched backbone polysaccharide provide a conformational rationale for the different antigenic epitopes identified for these PS. We find that side chains stabilize the proximal β dGlc(1→6) β dGlcNAc backbone linkage, restricting rotation and creating a well-defined conformational epitope at the branch point. This agrees with the glycotope structure recognized by an anti-GBSIII PS functional monoclonal antibody. We find the same dominant solution conformation for GBSIII and Pn14 PS: aside from the branch point, the backbone is very flexible with a “zig-zag” conformational habit, rather than the helix previously proposed for GBSIII PS. This suggests a common strategy for bacterial evasion of the host immune system: a flexible backbone that is less perceptible to the immune system, combined with conformationally-defined branch points presenting human-mimic epitopes. This work demonstrates how small structural features such as side chains can alter the conformation of a polysaccharide by restricting rotation around backbone linkages. DA - 2019-02-13 DB - OpenUCT DP - University of Cape Town IS - 1 J1 - Pharmaceuticals KW - capsular polysaccharide LK - https://open.uct.ac.za PY - 2019 T1 - Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study TI - Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study UR - http://hdl.handle.net/11427/30191 ER - en_ZA
dc.identifier.uri10.3390/ph12010028
dc.identifier.urihttps://www.mdpi.com/1424-8247/12/1/28
dc.identifier.urihttp://hdl.handle.net/11427/30191
dc.identifier.vancouvercitationKuttel MM, Ravenscroft N. Conformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study. Pharmaceuticals. 2019;12(1):28. http://hdl.handle.net/11427/30191.en_ZA
dc.language.isoenen_US
dc.publisher.departmentDepartment of Computer Scienceen_US
dc.publisher.facultyFaculty of Scienceen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourcePharmaceuticalsen_US
dc.source.journalissue1en_US
dc.source.journalvolume12en_US
dc.source.pagination28en_US
dc.source.urihttps://www.mdpi.com/journal/pharmaceuticals
dc.subjectcapsular polysaccharideen_US
dc.subject.othercarbohydrate antigen
dc.subject.othermolecular modeling
dc.subject.otherGroup B Streptococcus
dc.subject.otherStreptococcus pneumoniae
dc.subject.otherconjugate vaccines
dc.titleConformation and cross-protection in Group B Streptococcus serotype III and Streptococcus pneumoniae serotype 14: a molecular modeling study.en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kuttel2019.pdf
Size:
2.51 MB
Format:
Adobe Portable Document Format
Description:
main article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections